Skip to main content

Site notifications

(Approval lapsed 05/03/2021) Pethidine 100mg/2mL Solution for Injection, 2mL ampoule (Martindale)

Section 19A approved medicine
(Approval lapsed 05/03/2021) Pethidine 100mg/2mL Solution for Injection, 2mL ampoule (Martindale)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Lapsed
Medicines in short supply/unavailable
DBL PETHIDINE HYDROCHLORIDE 100mg/2mL injection BP ampoule - ARTG 107387
Indication(s)

Pethidine 50 mg/mL Solution for Injection ampoules (50 mg/mL & 100 mg/2 mL) are approved for use under Section 19A for the following indications:

  • For short term (24 to 36 hours) management of severe pain.
  • For administration as an anaesthetic adjunct and for obstetric analgesia.
Published

Help us improve the Therapeutic Goods Administration site